Home > Technology > PSMEL - IGSME

printbutton

PSMEL® / IGSME®

  

A vast library of drug-like compounds (PSMEL®) is being generated in silico at Prous Institute through a multistep process (IGSME®) to fulill the needs of the Epistemic Drug Discovery®  project on autophagy and apoptosis modulation and type 2 diabetes. 

   

Applications

 
The large chemical space created by PSMEL is orbited by i-DDS, allowing the selection of compounds to be assessed for biological activity. In this space, it is possible to make serendipitous discoveries.
 
 
 
 

Billions of chemicals are waiting to be tested for their potential therapeutic activity. Sophisticated software and powerful computers provide the most potent in silico strategies for drug discovery and development at Prous Institute.